Biostage appoints Jerry He as CEO, replacing David Green; sets compensation terms

Harvard Apparatus Regenerative Technology, Inc.

Jerry He appointed Chairman and CEO effective March 1, 2023; David Green remains on board.
Base salary $300,000, rising to $500,000 if private placement raises ≥$4M.
Time-based option grant: 732,384 shares; milestone grant up to 488,256 shares.
If offering raises <$4M, annual option grant valued at $200,000 in lieu of additional cash.
Annual bonus up to 100% of base salary.

item 3.02 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

David Green

Chairman and Chief Executive Officer

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2023-03-01
Successor: Junli (Jerry) He
Filed: March 14, 2023, 7:59 PM ET

the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.

Appointed

Junli (Jerry) He

Chairman and Chief Executive Officer

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2023-03-01
Filed: March 14, 2023, 7:59 PM ET

the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Green changed role as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..

Action: replaced
Role: Chairman and Chief Executive Officer

Exact text from the filing

the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Junli (Jerry) He was appointed as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..

Action: appointed
Role: Chairman and Chief Executive Officer

Exact text from the filing

the Company’s existing director, Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.

View on SEC.gov

Harvard Apparatus Regenerative Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-007607

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.